心脏手术后新发心房颤动的抗凝处方模式
该研究利用行政数据库纳入2015年1月1日至2020年12月31日心脏手术后新发心房颤动的成人患者,共3214例,其中878例(27.3%)出院时被处方口服抗凝药,536例(61%)用华法林,342例(39%)用直接口服抗凝药,超过半数患者(56.1%)在6个月内停用口服抗凝药。处方抗凝与否在30天、3个月或6个月时卒中或系统性栓塞无差异,但接受任何口服抗凝药者在所有时间点出血率更高。
要点
- 心脏手术后新发房颤患者中仅27.3%出院时处方口服抗凝药,华法林占61%。
- 56.1%的患者在6个月内停用口服抗凝药。
- 处方抗凝与未处方者卒中或系统性栓塞无差异,但处方者所有时间点出血率更高。
核心结论
- 心脏手术后新发房颤患者中少数被处方口服抗凝药,华法林是最常用药物;口服抗凝药启动与出血风险增加相关,在评估患者卒中风险与术后出血风险增加时需特别考虑。
研究设计与样本
- 利用行政数据库纳入2015年1月1日至2020年12月31日期间心脏手术后新发心房颤动的成人患者,共3214例。
- 关键排除标准包括既往心房颤动、机械瓣置换或索引入院前6个月内处方抗凝药配药。
主要发现
- 878例(27.3%)出院时被处方口服抗凝药,其中536例(61%)处方华法林,342例(39%)处方直接口服抗凝药。
- 超过半数患者(56.1%)在6个月内停用口服抗凝药。
- 处方与未处方抗凝者在30天、3个月或6个月时卒中或系统性栓塞无差异。
- 接受任何口服抗凝药者在所有时间点任何出血发生率更高。
临床怎么用
- 原文未据此给出推荐,作者在结论中指出口服抗凝药启动与出血风险增加相关,在评估患者卒中风险与术后出血风险增加时需特别考虑。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative atrial fibrillation (POAF) is a common complication after cardiac surgery and is associated with an increased risk of thromboembolic stroke. Recommendations regarding the optimal anticoagulant, timing of initiation, and duration of therapy remain uncertain. METHODS: Administrative databases were used to include adult patients who presented with POAF after cardiac surgery between January 1, 2015, and December 31, 2020. Key exclusion criteria included preexisting atrial fibrillation, mechanical valve replacement, or anticoagulant prescription fill within 6 months before the index admission. RESULTS: A total of 3214 of patients were included, and 878 (27.3%) were prescribed an oral anticoagulant (OAC) on discharge, with 536 (61%) prescribed warfarin and 342 (39%) prescribed a direct OAC. More than half of the patients (56.1%) stopped their OAC by 6 months. There was no difference in stroke or systemic embolism at 30 days, 3 months, or 6 months between those with and without anticoagulation prescribed. However, those on any OAC had higher rates of any bleeding at all time points. CONCLUSIONS: A minority of patients who presented with POAF after cardiac surgery were prescribed OAC, with warfarin being the most common agent. OAC initiation was associated with increased bleeding risk, warranting special consideration when assessing a patient's risk of stroke with the increased risk of bleeding, particularly in the postoperative period.
引用
- Krahn KM, Koshman SL, Wang T, et al. Anticoagulant Prescribing Patterns in New-Onset Atrial Fibrillation After Cardiac Surgery. Ann Thorac Surg. 2023. PMID: 38081497. doi:10.1016/j.athoracsur.2023.11.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。